Anagrelide and cardiac failure Patient Reports February 11, 2012
Anagrelide Side Effects Report #5031336-1
Anagrelide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 21, 2005. Male patient, 74 years of age, weighting 189.6 lb, was diagnosed with thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: cardiac failure. Anagrelide dosage: 1 MG, 1X/DAY:QD,ORAL. During the same period patient was treated with FUROSEMIDE, ALLOPURINOL, HYDROXYCARBAMIDE, IPRATROPIUM. Patient was hospitalized. Patient recovered.
Anagrelide Side Effects Report #5906740-7
Anagrelide side effect was reported by a Physician from BELGIUM on Sept 18, 2008. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac arrest
, cardiac failure, white blood cell count increased. Anagrelide dosage: 1 MG, 2X/DAY:BID,. During the same period patient was treated with HYDROXYUREA, ACETYLCYSTEINE, TENORETIC, IRBESARTAN. Patient died on 09/01/2008.Anagrelide Side Effects Report #5031333-6
Anagrelide side effect was reported by a Physician from FRANCE on Mar 16, 2005. Male patient, 76 years of age, weighting 194.0 lb, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: bronchitis
, cardiac failure, gamma-glutamyltransferase increased, renal failure. Anagrelide dosage: 0.5 MG,2X/DAY:BID. Patient was hospitalized. Patient recovered.Anagrelide Side Effects Report #5856763-1
Anagrelide side effect was reported by a Health Professional from SPAIN on Aug 07, 2008. Female patient, 68 years of age, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: cardiac failure, dilatation ventricular, portal hypertension, pulmonary hypertension
, right atrial dilatation. Anagrelide dosage: 0.5 MG, 1X/DAY:QD,. During the same period patient was treated with SEGURIL, PLAVIX, AMLODIPINE, LOSARTAN POTASSIUM, DIGOXIN. Patient was hospitalized. Patient recovered.
Anagrelide and cardiac failure 